Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Capsule: SOP for Processing Overages in Capsule Formulations – V 2.0

Posted on By

Capsule: SOP for Processing Overages in Capsule Formulations – V 2.0

Standard Operating Procedure for Processing Overages in Capsule Formulations

Department Capsule Manufacturing
SOP No. SOP/CM/110/2025
Supersedes SOP/CM/110/2022
Page No. Page 1 of 6
Issue Date 01/02/2025
Effective Date 05/02/2025
Review Date 01/02/2026

1. Purpose

The purpose of this SOP is to define the procedure for processing overages in capsule formulations. Overages are typically added to compensate for losses during the manufacturing process, ensuring that each capsule contains the required amount of active pharmaceutical ingredient (API). This SOP ensures that overages are processed accurately, safely, and in compliance with GMP standards.

2. Scope

This SOP applies to all formulations in capsule manufacturing that involve the addition of overages, including both hard and soft gelatin capsules. It covers the calculation, preparation, and processing of overages during the capsule filling process.

3. Responsibilities

  • Production Operators: Responsible for accurately preparing and processing the overage according to the specified formulation. They must ensure that the correct overage amount is added during production.
  • Quality Control (QC) Team: Responsible for verifying the overage content, ensuring that it complies with the required specifications, and performing checks on the final product.
  • Quality Assurance (QA) Team: Ensures compliance with
SOP, verifies documentation, and reviews any deviations or discrepancies related to overage processing.
  • Production Supervisor: Oversees the entire process, ensures correct procedures are followed, and coordinates between production, QC, and QA teams.
  • 4. Accountability

    The Capsule Manufacturing Supervisor is accountable for ensuring that the overage process is executed as per this SOP and in compliance with regulatory standards. The QA Manager is responsible for reviewing and approving the overage processing procedure, ensuring that the final product meets the required specifications.

    5. Procedure

    5.1 Calculating the Overage

    Overages are typically calculated based on the estimated loss during manufacturing and the required API dosage per capsule. The following steps must be followed:

    1. Determine the Required Overage Percentage

      1. Consult the product formulation sheet to determine the overage percentage required for the specific formulation.
      2. Common overage percentages range from 2% to 5% but may vary depending on the formulation and manufacturing process.
    2. Calculate the Total Amount of Active Ingredient

      1. Calculate the total required API based on the number of capsules to be produced and the required dosage per capsule.
      2. Apply the overage percentage to the total API required to determine the additional quantity to be added to the batch.
    3. Calculate the Total Weight of Ingredients

      1. Calculate the total weight of the formulation ingredients, including the active ingredient (API), excipients, and overage.
      2. Ensure that the final batch weight accounts for the overage to prevent under-dosing.

    5.2 Preparing the Overage

    Once the overage amount is calculated, proceed with preparing the overage for inclusion in the capsule filling process:

    1. Prepare API and Excipients

      1. Weigh the required amount of API and excipients using a calibrated balance, ensuring accuracy within the required tolerance limits.
      2. Prepare the ingredients as specified in the formulation sheet, mixing them in the correct proportions, including the calculated overage.
    2. Record the Preparation

      1. Document the weights of all ingredients, including the overage, in the Batch Record (Annexure-1). Ensure that any changes made during the preparation are also recorded.
      2. Ensure that the preparation log includes the batch number, date, and names of personnel involved in preparing the overage.

    5.3 Processing the Overage During Capsule Filling

    During the capsule filling process, the overage is added to the capsule formulation to compensate for losses. The following steps should be followed:

    1. Check Capsule-Filling Machine Settings

      1. Ensure that the capsule filling machine is calibrated to accommodate the overage amount and that it can handle any increase in the total weight of the capsule contents.
      2. Verify that the fill weight system is calibrated, ensuring that the added overage does not lead to excessive variation in capsule weight.
    2. Add the Overage to the Capsule Filler

      1. Ensure the overage is added to the capsule filling system as per the calculated amount. This may require adding the overage in small portions to ensure uniform distribution throughout the batch.
      2. Record the addition of overage in the production log.
    3. Monitor Capsule Weight

      1. After adding the overage, perform weight checks on randomly selected capsules throughout the production run to ensure that the weight is within acceptable limits.
      2. If any capsules fall outside the acceptable weight range, investigate and correct the filling process.

    5.4 Quality Control and Final Checks

    Quality control checks must be conducted to verify that the overage was correctly processed and that the final product meets specifications:

    1. Capsule Weight Testing

      1. Test a random sample of filled capsules to verify that the weight is within the specified range.
      2. Ensure that the weight consistency is maintained across the entire batch, accounting for the overage.
    2. Uniformity of Content Testing

      1. Perform content uniformity testing to ensure that the amount of API in the capsules is consistent and within the required limits.
    3. Final Product Inspection

      1. Inspect the final batch for any visual defects, such as cracks, leaks, or incomplete seals. If any defects are found, initiate a corrective action as necessary.

    5.5 Documentation and Reporting

    Proper documentation of the overage processing procedure is essential for traceability and regulatory compliance:

    1. Record All Data

      1. Record all relevant data, including overage calculations, preparation logs, batch records, and QC testing results, in the appropriate production logs (Annexure-1, Annexure-2, etc.).
    2. Report Deviations

      1. Any deviation from the standard overage processing procedure must be documented in the Deviation Log (Annexure-3), with corrective actions noted and reviewed by the QA team.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • GMP: Good Manufacturing Practice
    • QC: Quality Control
    • QA: Quality Assurance
    • API: Active Pharmaceutical Ingredient

    7. Documents

    1. Batch Record (Annexure-1)
    2. Capsule Weight and Fill Volume Log (Annexure-2)
    3. Deviation Log (Annexure-3)
    4. Maintenance Log (Annexure-4)

    8. References

    • USP <1163> – Pharmaceutical Dosage Forms: Capsules
    • FDA Guidelines for Capsule Manufacturing
    • Good Manufacturing Practice (GMP) Guidelines

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Batch Record

    Batch ID Gelatin Composition API Quantity Overage Percentage Added Overage Operator Approval Status
    Batch 001 Standard 500mg 5% 25mg Jane Smith Approved

    Annexure-2: Capsule Weight and Fill Volume Log

    Sample ID Capsule Weight (mg) Fill Volume (mL) Pass/Fail Operator
    Sample 001 550 1.2 Pass John Doe

    Annexure-3: Deviation Log

    Deviation ID Batch ID Description Corrective Action Operator Approval Status
    DEV-001 Batch 001 Overage addition error Recalculated overage and adjusted dosage Jane Smith Approved

    Annexure-4: Maintenance Log

    Annexure-4: Maintenance Log
    Equipment ID Maintenance Date Maintenance Activity Performed By Next Maintenance Due
    Filling Machine 001 02/02/2025 Recalibrated filling system to accommodate overage John Doe 02/02/2026

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial version New SOP Creation QA Head
    01/02/2025 2.0 Added detailed corrective actions for overage discrepancies Improved documentation and accuracy QA Head
    See also  Capsule: SOP for Capsule Size Customization for Clinical Trials - V 2.0
    Capsules V 2.0 Tags:Active pharmaceutical ingredients (APIs) Capsule excipients, Capsule batch records, Capsule cleaning procedures, Capsule content uniformity, Capsule deviation management, Capsule disintegration testing, Capsule dissolution testing, Capsule filling process, Capsule inspection techniques, Capsule labeling requirements, Capsule maintenance protocols, Capsule Manufacturing, Capsule manufacturing equipment, Capsule packaging standards, Capsule process validation, Capsule production scheduling, Capsule Quality Control, Capsule regulatory compliance, Capsule safety guidelines, Capsule sealing methods, Capsule size specifications, Capsule stability testing, Capsule storage conditions, Capsule training programs, Empty capsule shells, Hard gelatin capsules, Pharmaceutical capsules, Soft gelatin capsules, Vegetarian capsules

    Post navigation

    Previous Post: Ointments: SOP for Recording and Investigating Non-Conformance Reports – V 2.0
    Next Post: Tablets: SOP for Cleaning Checks Between Granulation Batches – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version